T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 12/31/2014
Volatility and Other Measures
as of 12/31/2014
Beta 1.04
0.47
Standard Deviation 13.57
Price/Earnings Ratio (Domestic) 22.3
Earnings Growth Rate (Domestic) 14.7
Turnover Rate N/A
Median Market
Capitalization
$31,241.51 Million
10 Largest Holdings
Represents 33.25 % of Total Net Assets
View Holdings as of:
Actavis
Aetna
Alexion Pharmaceuticals
Allergan
Biogen Idec
Danaher
Gilead Sciences
McKesson
UnitedHealth Group
Valeant Pharmaceuticals International
As of 12/31/2014 the Health Sciences Fund had a total of 160 holdings.
Sector Diversification
as of 12/31/2014
% of Total Net Assets
Biotechnology 31.3%
Services 24.8%
Pharmaceuticals 23.5%
Products & Devices 11.7%
Life Sciences 3.6%
Miscellaneous 2.7%
See Glossary for additional details on all data elements.